Massive new review exposes exercise as largely ineffective for osteoarthritis pain relief, challenging decades of government-backed health mandates that wasted patient time and resources.
Story Highlights
- Umbrella review of over 12,000 participants finds only small, short-term pain relief for knee OA (10.8-12.4 points on 0-100 scale), negligible for hip OA.
- Effects fade in larger, longer trials; evidence certainty very low, below clinical importance threshold of 12 points.
- Researchers reject exercise as universal first-line treatment, urge shared decisions over blanket guidelines.
- Published February 2026 in RMD Open, contradicting prior Cochrane data and entrenched policies from NICE/ACR.
Review Details and Findings
The RMD Open umbrella systematic review synthesized five prior reviews and 28 additional trials involving over 12,000 participants with osteoarthritis in knees, hips, hands, ankles, and other sites. Exercise provided small short-term pain relief for knee OA, with mean differences of -10.8 to -12.4 points versus placebo or no treatment on a 0-100 scale. Evidence certainty rated very low. Hip OA showed negligible effects with moderate certainty, while hand OA had small effects. Benefits diminished in rigorous, larger-scale, longer-term studies.
Challenge to Long-Standing Guidelines
Clinical guidelines from NICE and ACR have promoted exercise as first-line non-drug therapy for OA since the 1980s-1990s, based on early trials showing modest muscle strengthening and function gains. This review questions that universality, noting inconsistencies in long-term efficacy and joint-specific results. Unlike the 2023 Cochrane update, which reported low-to-moderate certainty for 8.7-13.1 point gains mainly in knees, the umbrella approach across joints highlights smaller effects often below the minimal important difference of 12 points.
Stakeholders and Power Dynamics
Researchers from the RMD Open team, motivated by guideline discrepancies and sparse long-term data, aim to refine OA management through clinically interpretable synthesis. Guideline bodies like Cochrane and ACR hold high influence as policy shapers, while clinicians and physiotherapists implement treatments. Patients and advocacy groups drive preferences. Tensions exist between evidence skeptics and exercise promoters emphasizing holistic benefits like cardiovascular health.
Implications for Patients and Policy
OA affects 10-15% of adults over 60, mainly knees and hips, amid rising cases from aging and obesity. Short-term, the review may curb automatic exercise prescriptions, encouraging alternatives like manual therapy or analgesics. Long-term, it pushes multimodal care, subgroup research, and optimal exercise types. This empowers patient choice, potentially saves healthcare costs by avoiding ineffective interventions, and pressures updates to rigid guidelines favoring low-risk exercise over proven options.
Expert Views and Uncertainties
Review authors describe effects as negligible or short-lasting small, less in larger trials, but stress non-pain benefits. Medical News Today highlights the goal of joint-wide interpretability. Cochrane supports slight safe gains, yet consensus views exercise as low-cost but no panacea. Uncertainties include exercise subtypes (aerobic better than stretching), baseline severity responses, and limited long-term data. No post-publication rebuttals noted as of February 26, 2026.
Sources:
PubMed abstract (RMD Open study)
